Investigation of the inhibitors of histone-lysine N-methyltransferase SETD2 for acute lymphoblastic leukaemia from traditional Chinese medicine

References

• A.V. Krivtsov and S.A. Armstrong, MLL translocations, histone modifications and leukaemia stem-cell development, Nat. Rev. Cancer 7 (2007), pp. 823–833.
   PubMed Web of Science ®Google Scholar
• T. Yamamoto, W.-C. Hung, T. Takano, and A. Nishiyama, Genetic nature and virulence of community-associated methicillin-resistant Staphylococcus aureus, BioMedicine 3 (2013), pp. 2–18.
   Google Scholar
• J.J. Hutter, Childhood leukemia, Pediatr. Rev. 31 (2010), pp. 234–241.
   PubMed Web of Science ®Google Scholar
• J.W. Vardiman, J. Thiele, D.A. Arber, R.D. Brunning, M.J. Borowitz, A. Porwit, N.L. Harris, M.M. Le Beau, E. Hellstrom-Lindberg, A. Tefferi, and C.D. Bloomfield, The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes, Blood 114 (2009), pp. 937–951.
   PubMed Web of Science ®Google Scholar
• Y. Zhang, M. Gostissa, D.G. Hildebrand, M.S. Becker, C. Boboila, R. Chiarle, S. Lewis, and F.W. Alt, The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers, Adv. Immunol. 106 (2010), pp. 93–133.
   PubMed Web of Science ®Google Scholar
• Y. Zhang and J.D. Rowley, Chromatin structural elements and chromosomal translocations in leukemia, DNA Repair (Amst) 5 (2006), pp. 1282–1297.
   PubMed Web of Science ®Google Scholar
• Y.-M. Chang, B.K. Velmurugan, W.-W. Kuo, Y.-S. Chen, T.-J. Ho, C.-T. Tsai, C.-X. Ye, C.-H. Tsai, F.-J. Tsai, and C.-Y. Huang, Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells, BioMedicine 3 (2013), pp. 148–152.
   Google Scholar
• I.C. Chou, W.-D. Lin, C.-H. Wang, Y.-T. Chang, Z.-N. Chin, C.-H. Tsai, and F.-J. Tsai, Association analysis between Tourette's syndrome and two dopamine genes (DAT1, DBH) in Taiwanese children, BioMedicine 3 (2013), pp. 88–91.
   Google Scholar
• Y. Jiang, X. Li, W. Yang, D.H. Hawke, Y. Zheng, Y. Xia, K. Aldape, C. Wei, F. Guo, Y. Chen, and Z. Lu, PKM2 Regulates chromosome segregation and mitosis progression of tumor cells, Molecular cell 53 (2014), pp. 75–87.
   PubMed Web of Science ®Google Scholar
• Y.M. Leung, K.L. Wong, S.W. Chen, D.Y. Lu, C.S. Kuo, Y.R. Chen, Y.W. Chen, and T.H. Cheng, Down-regulation of voltage-gated Ca2+ channels in Ca2+ store-depleted rat insulinoma RINm5F cells, BioMedicine 3 (2013), pp. 130–139.
   Google Scholar
• X. Zhu, F. He, H. Zeng, S. Ling, A. Chen, Y. Wang, X. Yan, W. Wei, Y. Pang, H. Cheng, C. Hua, Y. Zhang, X. Yang, X. Lu, L. Cao, L. Hao, L. Dong, W. Zou, J. Wu, X. Li, S. Zheng, J. Yan, J. Zhou, L. Zhang, S. Mi, X. Wang, Y. Zou, Y. Chen, Z. Geng, J. Wang, X. Liu, W. Yuan, G. Huang, T. Cheng, and Q.F. Wang, Identification of functional cooperative mutations of SETD2 in human acute leukemia, Nat. Genet. 46 (2014), pp. 287–293.
   PubMed Web of Science ®Google Scholar
• C.Y. Chen and C.Y.C. Chen, Insights into designing the dual-targeted HER2/HSP90 inhibitors, J. Molec. Graph. Model. 29 (2010), pp. 21–31.
   PubMed Web of Science ®Google Scholar
• S.C. Yang, S.S. Chang, H.Y. Chen, and C.Y.C. Chen, Identification of potent EGFR inhibitors from TCM Database@Taiwan, PLoS Comput. Biol. 7 (2011).
   Web of Science ®Google Scholar
• Y.A. Tsou, K.C. Chen, H.C. Lin, S.S. Chang, and C.Y.C. Chen, Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: A virtual screening and molecular dynamics study, PLoS ONE 7 (2012).
   Web of Science ®Google Scholar
• C.Y.C. Chen, TCM database@Taiwan: The world's largest traditional Chinese medicine database for drug screening in Silico, PLoS ONE 6 (2011), p. e15939.
   PubMed Web of Science ®Google Scholar
• C.Y. Chen and W.I. Tou, How to design a drug for the disordered proteins?, Drug Discov. Today 18 (2013), pp. 910–915.
   PubMed Web of Science ®Google Scholar
• W. Zheng, G. Ibanez, H. Wu, G. Blum, H. Zeng, A. Dong, F. Li, T. Hajian, A. Allali-Hassani, M.F. Amaya, A. Siarheyeva, W. Yu, P.J. Brown, M. Schapira, M. Vedadi, J. Min, and M. Luo, Sinefungin derivatives as inhibitors and structure probes of protein lysine methyltransferase SETD2, J. Am. Chem. Soc. 134 (2012), pp. 18004–18014.
   PubMed Web of Science ®Google Scholar
• B. Xue, R.L. Dunbrack, R.W. Williams, A.K. Dunker, and V.N. Uversky, PONDR-FIT: A meta-predictor of intrinsically disordered amino acids, Biochim. Biophys. Acta 2010 (1804), pp. 996–1010.
   Google Scholar
• C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 46 (2001), pp. 3–26.
   PubMed Web of Science ®Google Scholar
• C.M. Venkatachalam, X. Jiang, T. Oldfield, and M. Waldman, LigandFit: A novel method for the shape-directed rapid docking of ligands to protein active sites, J. Molec. Graph. Model. 21 (2003), pp. 289–307.
   PubMed Web of Science ®Google Scholar
• B.R. Brooks, R.E. Bruccoleri, B.D. Olafson, D.J. States, S. Swaminathan, and M. Karplus, CHARMM: A program for macromolecular energy minimization and dynamics calculations, J. Comput. Chem. 4 (1983), pp. 187–217.
   Web of Science ®Google Scholar
• A.C. Wallace, R.A. Laskowski, and J.M. Thornton, LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions, Protein Eng. 8 (1995), pp. 127–134.
   PubMedGoogle Scholar
• R.A. Laskowski and M.B. Swindells, LigPlot+: Multiple ligand–protein interaction diagrams for drug discovery, J. Chem. Inf. Model. 51 (2011), pp. 2778–2786.
   PubMed Web of Science ®Google Scholar
• B. Hess, C. Kutzner, D. van der Spoel, and E. Lindahl, GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation, J. Chem. Theor. Comput. 4 (2008), pp. 435–447.
   PubMed Web of Science ®Google Scholar
• V. Zoete, M.A. Cuendet, A. Grosdidier, and O. Michielin, SwissParam: A fast force field generation tool for small organic molecules, J. Comput. Chem. 32 (2011), pp. 2359–2368.
   PubMed Web of Science ®Google Scholar
• R. Fletcher, Optimization, Academic Press, New York and London, 1969.
   Google Scholar
• V.N. Maiorov and G.M. Crippen, Size-independent comparison of protein three-dimensional structures, Proteins 22 (1995), pp. 273–283.
   PubMed Web of Science ®Google Scholar
• R. Chen and D. Yu, Studies on the chemical constituents of coniselinum vaginatum thell, Acta Pharm. Sinica 30 (1995), pp. 526–530.
   Google Scholar
• Y. Xiong, K.Z. Deng, Y.Q. Guo, W.Y. Gao, and T.J. Zhang, New chemical constituents from the rhizomes of Sparganium stoloniferum, Arch. Pharm. Res. 32 (2009), pp. 717–720.
   PubMed Web of Science ®Google Scholar
• T. Yi, K.S. Leung, G.H. Lu, H. Zhang, and K. Chan, Identification and comparative determination of senkyunolide A in traditional Chinese medicinal plants Ligusticum chuanxiong and Angelica sinensis by HPLC coupled with DAD and ESI-MS, Chem. Pharm. Bull. 53 (2005), pp. 1480–1483.
   PubMed Web of Science ®Google Scholar
• L. Chen, J. Qi, Y.X. Chang, D. Zhu, and B. Yu, Identification and determination of the major constituents in traditional Chinese medicinal formula Danggui-Shaoyao-San by HPLC-DAD-ESI-MS/MS, J. Pharm. Biomed. Anal. 50 (2009), pp. 127–137.
   PubMed Web of Science ®Google Scholar
• Z. Ma, W. Xu, L.Y. Liu-Chen, and D.Y. Lee, Novel coumarin glycoside and phenethyl vanillate from Notopterygium forbesii and their binding affinities for opioid and dopamine receptors, Bioorg. Medicinal Chem. 16 (2008), pp. 3218–3223.
   PubMed Web of Science ®Google Scholar